The decline in net interest income and net income signals margin compression and higher provision costs. Watch for further details on NIM trends, credit quality, and the closing of the healthcare restructuring which may unlock value. The stock may face near-term pressure from the weaker earnings.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 7 $3.33entry
- T+1 · 6mo ago +1.20%α +0.37% · $3.37
- T+5 · 6mo ago −5.11%α −6.61% · $3.16
- T+20 · 6mo ago −9.01%α −12.14% · $3.03
- T+60 · 4mo ago −1.50%α −5.33% · $3.28
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Bradesco's Q1 2026 net income fell 7.8% YoY to R$5.23B from R$5.68B, with net interest income declining 22.4% to R$17.33B from R$22.35B. EPS dropped to R$0.47 (common) and R$0.51 (preferred) from R$0.50 and R$0.56, respectively. The bank also announced a corporate restructuring to consolidate its healthcare business under Odontoprev (now Bradsaúde).
Key Facts
- Net income decreased 7.8% YoY to R$5.23B in Q1 2026 from R$5.68B in Q1 2025.
- Net interest income dropped 22.4% YoY to R$17.33B from R$22.35B.
- Basic EPS: common R$0.47 (vs R$0.50), preferred R$0.51 (vs R$0.56).
- Total loan portfolio grew 8.4% YoY to R$799.2B.
- Capital increased to R$93.77B via reserve capitalization; R$3.95B interest on equity provisioned.
- Corporate restructuring to consolidate health business under Odontoprev/Bradsaúde announced in February 2026, approved in April 2026.
Financial Impact
Net income down ~R$445M YoY; net interest income down ~R$5.0B YoY.
Risk Factors
- Further net interest margin compression due to elevated interest rates and funding costs.
- Increase in credit losses if economic conditions worsen.
- Execution risk in healthcare restructuring; potential dilution from Odontoprev share issuance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001292814-26-002867 |
| Document: 0001292814-26-002867-index-headers.html | 0001292814-26-002867 |
| Document: 0001292814-26-002867-index.html | 0001292814-26-002867 |
| Document: 0001292814-26-002867.txt | 0001292814-26-002867 |
Track record
8 reports on BBDO
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +6.73% at T+60 after the Jun 11, 2026 report. 3 of 3 went positive at some point.
Filters
- Jun 11, 202622w ago Institutional Cluster Bullish 5/10 Entry $2.97 to $3.02 Now $2.24 −24.58% ▲ +1.68% +1.14% vs SPY
- May 29, 202624w ago 6-K Neutral 3/10 Entry $3.13 to $3.20 Now $2.24 −28.35% ▲ +2.24% +1.98% vs SPY
- May 13, 202626w ago 6-K Neutral 2/10 Entry $3.16 to $3.18 Now $2.24 −29.11% ▲ +0.63% −0.14% vs SPY
- May 7, 202627w ago 6-K Bullish 7/10 Entry $3.33 to $3.37 Now $2.24 −32.73% ▲ +1.20% +0.37% vs SPY
- May 7, 202627w ago 6-K Bearish 6/10 Viewing Entry $3.33 to $3.37 Now $2.24 +32.73% ▼ −1.20% −0.37% vs SPY
- May 7, 202627w ago 6-K Bullish 7/10 Entry $3.33 to $3.37 Now $2.24 −32.73% ▲ +1.20% +0.37% vs SPY
- Apr 10, 202631w ago 6-K Neutral 2/10 Entry $3.68 to $3.71 Now $2.24 −39.08% ▲ +0.90% −0.31% vs SPY
- Mar 30, 202633w ago 6-K Neutral 4/10 Entry $3.23 to $3.29 Now $2.24 −30.72% ▲ +1.91% +1.16% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers